5Soil R, Ozek E. Multiple versus single doses oF exoge- nous surfactant for the prevention or treatment of neo- natal respiratory distress syndrome[J. Cochrane Database Syst Rev,2009,21(1): 141-143. 被引量：1
6Clarke P. Chronic lung disease[J], Avery,s diseases of thenew born,2008,8(5) :58-59. 被引量：1
7Thomas H. Current use of nasal continous positive air-way spmssuminne on ates[J], Litter, 2008,11(7): 106-108. 被引量：1
8Pantalitschka T, S ievers J, Urschitz M S,et al. Ran-domised crossover trial of four nasal respiratory supportsystems for apnoea of prematurity in very low birthweight infants [J] . Arch Dis Child Fetal Neonatal Ed,2009,94 (4): 245-248. 被引量：1
9Nakahara H, Lee S, Sugihara G, et al. Langmuir monolayer of artifi- cial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfae- ten (Surfactant TA) [J]. Langmuir, 2008, 24(7): 3370-3379. 被引量：1
10Lukovic D, Plaseneia I, Tabemer FJ, et al. Production and character- isation of recombinant forms of human pulmonary surfactant pro- tein C (SP-C): Slructure and surface activity [J]. Biochim Biophys Acta, 2006, 1758(4): 509-518. 被引量：1
